InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong
· Delayed Price · Currency is HKD 64.30
+2.10 (3.38%)
At close: Apr 29, 2026
HKG:3696 Revenue
In the year 2025, InSilico Medicine Cayman TopCo had annual revenue of $56.24M USD, down -34.48%. InSilico Medicine Cayman TopCo had revenue of $28.78M in the half year ending December 31, 2025.
Revenue
$56.24M
Revenue Growth
-34.48%
P/S Ratio
84.08
Revenue / Employee
$177.41K
Employees
317
Market Cap
36.81B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.24M | -29.60M | -34.48% |
| Dec 31, 2024 | 85.83M | 34.65M | 67.71% |
| Dec 31, 2023 | 51.18M | 21.03M | 69.77% |
| Dec 31, 2022 | 30.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition